Is Bionano Genomics struggling financially?

Yes, by its own account. Bionano Genomics told the SEC on 13 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

15/100

Critical

Sector: Industrial/Cyclical
Market cap: $14.1M
Source filing: 10-Q 13 May 2026
Balance sheet: 30 Jun 2026

Cash runway

1month

If the burn speeds up

Empty by Jul 2026
2months

If it eases off

Empty by Aug 2026

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$3.7M

Cash burned over the last 12 months

$32.4M

What Bionano Genomics told the SEC

…efforts. Management has prepared cash flows forecasts which indicate that based on the Company’s expected operating losses and negative cash flows, there is substantial doubt about the Company’s ability to continue as a going concern within twelve months after the date that the unaudited condensed consolidated financial statements for the three months ended March 31, 2026, are issued. Management’s ability to…

Bionano Genomics, Inc., Form 10-Q, filed 13 May 2026.

Read the filing on SEC.gov

What this means

Not a bankruptcy filing, and not a prediction.
It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

266.9% share-count increase The company issued stock. Each share now owns 72.7% less of the business than a year ago, before any change in the price.
Cash burn is narrowing It is spending 58% less cash per year than it was, so the runway above is lengthening rather than shortening.

Cash runway

The runway math

What Bionano Genomics told the SEC

What this means

What else the numbers show

Other Industrial/Cyclical companies that filed the doubt